These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25614393)

  • 1. Usefulness of diagnostic indices comprising clinical, sonographic, and biomarker data for discriminating benign from malignant ovarian masses.
    Stukan M; Dudziak M; Ratajczak K; Grabowski JP
    J Ultrasound Med; 2015 Feb; 34(2):207-17. PubMed ID: 25614393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.
    Hidalgo JJ; Ros F; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana Á; Alcázar JL
    Ultrasound Obstet Gynecol; 2019 May; 53(5):693-700. PubMed ID: 30353585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
    Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.
    Karlsen MA; Høgdall EV; Christensen IJ; Borgfeldt C; Kalapotharakos G; Zdrazilova-Dubska L; Chovanec J; Lok CA; Stiekema A; Mutz-Dehbalaie I; Rosenthal AN; Moore EK; Schodin BA; Sumpaico WW; Sundfeldt K; Kristjansdottir B; Zapardiel I; Høgdall CK
    Gynecol Oncol; 2015 Sep; 138(3):640-6. PubMed ID: 26086566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra- and interobserver agreement when describing adnexal masses using the International Ovarian Tumor Analysis terms and definitions: a study on three-dimensional ultrasound volumes.
    Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2013 Mar; 41(3):318-27. PubMed ID: 22915506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.
    Van Gorp T; Veldman J; Van Calster B; Cadron I; Leunen K; Amant F; Timmerman D; Vergote I
    Eur J Cancer; 2012 Jul; 48(11):1649-56. PubMed ID: 22226481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
    Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Effectiveness in Differentiating Benign from Malignant Ovarian Masses between IOTA Simple Rules and Subjective Sonographic Assessment.
    Tongsong T; Tinnangwattana D; Vichak-Ururote L; Tontivuthikul P; Charoenratana C; Lerthiranwong T
    Asian Pac J Cancer Prev; 2016; 17(9):4377-4380. PubMed ID: 27797247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting.
    Nunes N; Ambler G; Foo X; Widschwendter M; Jurkovic D
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):829-835. PubMed ID: 28976616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses.
    Lenhard M; Stieber P; Hertlein L; Kirschenhofer A; Fürst S; Mayr D; Nagel D; Hofmann K; Krocker K; Burges A
    Clin Chem Lab Med; 2011 Sep; 49(12):2081-8. PubMed ID: 21923475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Doppler ultrasonography in the diagnosis of ovarian cysts: indications, pertinence and diagnostic criteria].
    Marret H
    J Gynecol Obstet Biol Reprod (Paris); 2001 Nov; 30(1 Suppl):S20-33. PubMed ID: 11917373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of IOTA simple rules for adnexal masses classification: a comparison between two centers with different ovarian cancer prevalence.
    Ruiz de Gauna B; Rodriguez D; Olartecoechea B; Aubá M; Jurado M; Gómez Roig MD; Alcázar JL
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():10-4. PubMed ID: 26066289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of diagnostic models to estimate the risk of malignancy in adnexal masses.
    Van Holsbeke C; Van Calster B; Bourne T; Ajossa S; Testa AC; Guerriero S; Fruscio R; Lissoni AA; Czekierdowski A; Savelli L; Van Huffel S; Valentin L; Timmerman D
    Clin Cancer Res; 2012 Feb; 18(3):815-25. PubMed ID: 22114135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sonographic diagnosis of presumed benign ovarian tumors].
    Marret H; Cayrol M
    J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):730-43. PubMed ID: 24200073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prospective External Validation of International Ovarian Tumor Analysis (IOTA) Simple Rules in the Hands of Level I and II Examiners.
    Knafel A; Banas T; Nocun A; Wiechec M; Jach R; Ludwin A; Kabzinska-Turek M; Pietrus M; Pitynski K
    Ultraschall Med; 2016 Oct; 37(5):516-523. PubMed ID: 26126150
    [No Abstract]   [Full Text] [Related]  

  • 17. Reliability of preoperative evaluation of postmenopausal ovarian tumors.
    Niemi RJ; Saarelainen SK; Luukkaala TH; Mäenpää JU
    J Ovarian Res; 2017 Mar; 10(1):15. PubMed ID: 28288666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group.
    Timmerman D; Van Calster B; Testa AC; Guerriero S; Fischerova D; Lissoni AA; Van Holsbeke C; Fruscio R; Czekierdowski A; Jurkovic D; Savelli L; Vergote I; Bourne T; Van Huffel S; Valentin L
    Ultrasound Obstet Gynecol; 2010 Aug; 36(2):226-34. PubMed ID: 20455203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of sonographic subjective tumor assessment, IOTA logistic regression model 1, IOTA Simple Rules and GI-RADS system in the preoperative prediction of malignancy in women with adnexal masses.
    Koneczny J; Czekierdowski A; Florczak M; Poziemski P; Stachowicz N; Borowski D
    Ginekol Pol; 2017; 88(12):647-653. PubMed ID: 29303221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of multilayer perception artificial neutral networks for the prediction of the probability of malignancy in adnexal tumors].
    Smoleń A; Czekierdowski A; Stachowicz N; Kotarski J
    Ginekol Pol; 2003 Sep; 74(9):855-62. PubMed ID: 14674136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.